지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2004.6
- 수록면
- 143 - 151 (9page)
이용수
초록· 키워드
오류제보하기
This study was to investigate single and repeated-dose toxicities of CJ-11555, an anticirrhotic agent, in Sprague-Dawley (SD) rats. In single-dose oral toxicity study, the test article were
administered once by gavage to males and females at dose levels of 0 and 2,000 mg/kg. No dead animals and abnormal necropsy findings were found in control and CJ-11555 treated group. Therefore, the approximate lethal dose of CJ-11555 was considered to be higher than 2,000 mg/kg in rats. In the 4-week repeated oral toxicity study, the test article was administered once daily by gavage to
male and female rats at dose levels of 0, 10, 50 and 200 mg/kg/day for 4-weeks. In clinical signs, yellow-colored urine and yellow hair coat were observed in the 50 and 200 mg/kg male and female
groups. In hematology, erythrocyte count and hemoglobin were significantly decreased in the 200mg/kg male and female groups. In serum biochemistry, total cholesterol was significantly increased and aspartate aminotransferase (AST) was significantly decreased in the 50 or 200 mg/kg male and female groups. In histopathological examinations, centrilobular hepatocellular hypertrophy in the liver, congestion and pigmentation in the spleen, hyaline droplets in the kidney were observed in the 50 and 200 mg/kg male and female groups. In toxicokinetic study, CJ-11555 was dose-dependent in systemic exposure and showed better absorption in female with minimum accumulation after multidosing. Based on these results, it was concluded that the 4-week repeated oral dose of CJ-11555
resulted in the suppression of AST activity and centrilobular hepatocellular hypertrophy in both sexes at a dose level of 50 or 200 mg/kg/day. The target organ was estimated to be liver, spleen and male's kidney. The no-observed-adverse-effect level (NOAEL) for CJ-11555 in rats following gavage for at least 4-week is 10 mg/kg/day.
administered once by gavage to males and females at dose levels of 0 and 2,000 mg/kg. No dead animals and abnormal necropsy findings were found in control and CJ-11555 treated group. Therefore, the approximate lethal dose of CJ-11555 was considered to be higher than 2,000 mg/kg in rats. In the 4-week repeated oral toxicity study, the test article was administered once daily by gavage to
male and female rats at dose levels of 0, 10, 50 and 200 mg/kg/day for 4-weeks. In clinical signs, yellow-colored urine and yellow hair coat were observed in the 50 and 200 mg/kg male and female
groups. In hematology, erythrocyte count and hemoglobin were significantly decreased in the 200mg/kg male and female groups. In serum biochemistry, total cholesterol was significantly increased and aspartate aminotransferase (AST) was significantly decreased in the 50 or 200 mg/kg male and female groups. In histopathological examinations, centrilobular hepatocellular hypertrophy in the liver, congestion and pigmentation in the spleen, hyaline droplets in the kidney were observed in the 50 and 200 mg/kg male and female groups. In toxicokinetic study, CJ-11555 was dose-dependent in systemic exposure and showed better absorption in female with minimum accumulation after multidosing. Based on these results, it was concluded that the 4-week repeated oral dose of CJ-11555
resulted in the suppression of AST activity and centrilobular hepatocellular hypertrophy in both sexes at a dose level of 50 or 200 mg/kg/day. The target organ was estimated to be liver, spleen and male's kidney. The no-observed-adverse-effect level (NOAEL) for CJ-11555 in rats following gavage for at least 4-week is 10 mg/kg/day.
목차
ABSTRACT
서론
재료 및 방법
결과 및 고찰
결론
감사의 말씀
참고문헌
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
CJ-11555의 Sprague-Dawely 랫드를 이용한 단회 및 4주 반복경구투여 독성시험
Toxicological Research
2004 .03
-
A 4-week Repeated Oral Dose Toxicity Study of CJ-10882 in Dogs
Toxicological Research
2002 .09
-
CJ-50002(비브리오백신)의 랫드 및 비글개에서의 단회투여 독성시험
Toxicological Research
1999 .06
-
Toxicokinetics of CJ-11555: Gender Difference and Minimum Accumulation
대한약학회 학술대회
2003 .01
-
A 4-week Repeated Oral Dose Toxicity Study of Plant Sterol Esters in Sprague-Dawley Rats
Toxicological Research
2002 .03
-
General Pharmacological Study of CJ-11828, an Amlodipine adipate
The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology
2004 .01
-
CJ-11555의 안전성 약리실험
Toxicological Research
2004 .06
-
CJ-11555의 안전성 약리실험
Toxicological Research
2004 .03
-
새로운 Anthracycline계 항암성 항생물질 DA-125의 랫드에 대한 4주 용량설정시험(DRF)과 13주 아급성 독성시험
The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology
1994 .01
-
Pharmacokinetics of CJ-11555:Improvement of Bioavailability
대한약학회 학술대회
2003 .01
-
Difructose Dianhydrides(DFA IV)의 랫드를 이용한 단회 및 4주간 반복 경구투여 독성시험
Toxicological Research
2004 .09
-
杏仁의 랫트 단회 경구 투여 독성시험
대한한방내과학회지
2012 .01
-
4-Week repeated oral dose toxicity study of 1,4-dichlorobutane in rats
Laboratory Animal Research
2013 .03
-
14 Days Repeat Oral Dose Toxicity of Low Molecular Weight Fucoidan in Rats
Biomolecules & Therapeutics(구 응용약물학회지)
2010 .01
-
Reproductive and Developmental Toxicity Screening Test of Ethyl Hydrogen Adipate in Rats
Toxicological Research
2016 .10
-
비 마약성 진통제 DA-5018의 랫드에 대한 4주 경구투여 아급성독성
The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology
1997 .01
-
Toxicity Study of Red Ginseng Acidic Polysaccharide (RGAP) : Single and 2-week Repeated Oral Dose Toxicity Study in Rats
Toxicological Research
2003 .09
-
Acute and Repeated 28-Day Oral Dose Toxicity Studies of Thymus vulgaris L. Essential Oil in Rats
Toxicological Research
2019 .07
-
Acute and repeated dose 26-week oral toxicity study of 20(S)-ginsenoside Rg3 in Kunming mice and Sprague-Dawley rats
Journal of Ginseng Research
2020 .03
-
A Single Oral Dose Toxicity Study of Bamboo Leaf Water Extract in Sprague-Dawley Rats
The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology
2003 .01
이 논문의 저자 정보
이 논문과 함께 이용한 논문
Erythropoietin(EPO)에 대한 변이원성시험
제정환
,
이광훈
,
박진성
외 6명
Toxicological Research
1999
.09
백신 접종후 발생할 수 있는 전신적과민증 예측을 위한 아급성 실험동물 모형 개발과 관련 면역독성학적 지표치 평가
허용
,
김광호
Toxicological Research
2002
.06
Propylthiouracil을 이용한 OECD enhanced TG407의 내분비계 장애 물질검색을 위한 유효화 실험
강경선
,
김대용
,
제정환
외 11명
Toxicological Research
2001
.09
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2009-513-014287915